Skip to main navigation Skip to search Skip to main content

Randomized, Double-Blind, Placebo-Controlled, Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-Operative Nausea and Vomiting in High-Risk Patients

Project: Research

Project Details

StatusFinished
Effective start/end date04/1/1510/21/17

Funding

  • Premier Research International LLC: $55,581.81